Found 71 results
Author Title Type [ Year(Desc)]
Filters: Keyword is Mice  [Clear All Filters]
2010
N. Jearawiriyapaisarn, Moulton, H. M., Sazani, P., Kole, R., and Willis, M. S., “Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers.”, Cardiovasc Res, vol. 85, no. 3, pp. 444-53, 2010.
H. M. Moulton and Moulton, J. D., “Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy.”, Biochim Biophys Acta, vol. 1798, no. 12, pp. 2296-303, 2010.
U. Y. Schaff, Trott, K. A., Chase, S., Tam, K., Johns, J. L., Carlyon, J. A., Genetos, D. C., Walker, N. J., Simon, S. I., and Borjesson, D. L., “Neutrophils exposed to A. phagocytophilum under shear stress fail to fully activate, polarize, and transmigrate across inflamed endothelium.”, Am J Physiol Cell Physiol, vol. 299, no. 1, pp. C87-96, 2010.
L. Danelishvili, Yamazaki, Y., Selker, J., and Bermudez, L. E., “Secreted Mycobacterium tuberculosis Rv3654c and Rv3655c proteins participate in the suppression of macrophage apoptosis.”, PLoS One, vol. 5, no. 5, p. e10474, 2010.
2011
H. Yin, Moulton, H. M., Betts, C., and Wood, M., “CPP-directed oligonucleotide exon skipping in animal models of Duchenne muscular dystrophy.”, Methods Mol Biol, vol. 683, pp. 321-38, 2011.
B. W. Neuman, Bederka, L. H., Stein, D. A., Ting, J. P. C., Moulton, H. M., and Buchmeier, M. J., “Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.”, Antimicrob Agents Chemother, vol. 55, no. 10, pp. 4631-8, 2011.
A. Crisp, Yin, H., Goyenvalle, A., Betts, C., Moulton, H. M., Seow, Y., Babbs, A., Merritt, T., Saleh, A. F., Gait, M. J., Stuckey, D. J., Clarke, K., Davies, K. E., and Wood, M. J. A., “Diaphragm rescue alone prevents heart dysfunction in dystrophic mice.”, Hum Mol Genet, vol. 20, no. 3, pp. 413-21, 2011.
B. P. Dolan, Li, L., Veltri, C. A., Ireland, C. M., Bennink, J. R., and Yewdell, J. W., “Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance.”, J Immunol, vol. 186, no. 4, pp. 2065-72, 2011.
S. D. Farris, Hu, J. Hong, Krishnan, R., Emery, I., Chu, T., Du, L., Kremen, M., Dichek, H. L., Gold, E., Ramsey, S. A., and Dichek, D. A., “Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins.”, J Biol Chem, vol. 286, no. 25, pp. 22665-77, 2011.
M. McNabe, Tennant, R., Danelishvili, L., Young, L., and Bermudez, L. E., “Mycobacterium avium ssp. hominissuis biofilm is composed of distinct phenotypes and influenced by the presence of antimicrobials.”, Clin Microbiol Infect, vol. 17, no. 5, pp. 697-703, 2011.
2012
G. Chen, Severo, M. S., Sakhon, O. S., Choy, A., Herron, M. J., Felsheim, R. F., Wiryawan, H., Liao, J., Johns, J. L., Munderloh, U. G., Sutterwala, F. S., Kotsyfakis, M., and Pedra, J. H. F., “Anaplasma phagocytophilum dihydrolipoamide dehydrogenase 1 affects host-derived immunopathology during microbial colonization.”, Infect Immun, vol. 80, no. 9, pp. 3194-205, 2012.
E. S. Gold, Ramsey, S. A., Sartain, M. J., Selinummi, J., Podolsky, I., Rodriguez, D. J., Moritz, R. L., and Aderem, A., “ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol-induced lipid body formation.”, J Exp Med, vol. 209, no. 4, pp. 807-17, 2012.
J. L. Johns and Borjesson, D. L., “Downregulation of CXCL12 signaling and altered hematopoietic stem and progenitor cell trafficking in a murine model of acute Anaplasma phagocytophilum infection.”, Innate Immun, vol. 18, no. 3, pp. 418-28, 2012.
B. Wu, Lu, P., Cloer, C., Shaban, M., Grewal, S., Milazi, S., Shah, S. N., Moulton, H. M., and Lu, Q. Long, “Long-term rescue of dystrophin expression and improvement in muscle pathology and function in dystrophic mdx mice by peptide-conjugated morpholino.”, Am J Pathol, vol. 181, no. 2, pp. 392-400, 2012.
K. M. Sandoz, Eriksen, S. G., Jeffrey, B. M., Suchland, R. J., Putman, T. E., Hruby, D. E., Jordan, R., and Rockey, D. D., “Resistance to a novel antichlamydial compound is mediated through mutations in Chlamydia trachomatis secY.”, Antimicrob Agents Chemother, vol. 56, no. 8, pp. 4296-302, 2012.
2013
C. A. M. Silva, Danelishvili, L., McNamara, M., Berredo-Pinho, M., Bildfell, R., Biet, F., Rodrigues, L. S., Oliveira, A. V., Bermudez, L. E., and Pessolani, M. C. V., “Interaction of Mycobacterium leprae with human airway epithelial cells: adherence, entry, survival, and identification of potential adhesins by surface proteome analysis.”, Infect Immun, vol. 81, no. 7, pp. 2645-59, 2013.
S. Gopinath, Hotson, A., Johns, J. L., Nolan, G., and Monack, D., “The systemic immune state of super-shedder mice is characterized by a unique neutrophil-dependent blunting of TH1 responses.”, PLoS Pathog, vol. 9, no. 6, p. e1003408, 2013.
J. Meznarich, Malchodi, L., Helterline, D., Ramsey, S. A., Bertko, K., Plummer, T., Plawman, A., Gold, E., and Stempien-Otero, A., “Urokinase plasminogen activator induces pro-fibrotic/m2 phenotype in murine cardiac macrophages.”, PLoS One, vol. 8, no. 3, p. e57837, 2013.
2014
K. M. Sandoz, Valiant, W. G., Eriksen, S. G., Hruby, D. E., Allen, R. D., and Rockey, D. D., “The broad-spectrum antiviral compound ST-669 restricts chlamydial inclusion development and bacterial growth and localizes to host cell lipid droplets within treated cells.”, Antimicrob Agents Chemother, vol. 58, no. 7, pp. 3860-6, 2014.
M. Nizzardo, Simone, C., Salani, S., Ruepp, M. - D., Rizzo, F., Ruggieri, M., Zanetta, C., Brajkovic, S., Moulton, H. M., Müehlemann, O., Bresolin, N., Comi, G. P., and Corti, S., “Effect of combined systemic and local morpholino treatment on the spinal muscular atrophy Δ7 mouse model phenotype.”, Clin Ther, vol. 36, no. 3, pp. 340-56.e5, 2014.
S. A. Ramsey, Vengrenyuk, Y., Menon, P., Podolsky, I., Feig, J. E., Aderem, A., Fisher, E. A., and Gold, E. S., “Epigenome-guided analysis of the transcriptome of plaque macrophages during atherosclerosis regression reveals activation of the Wnt signaling pathway.”, PLoS Genet, vol. 10, no. 12, p. e1004828, 2014.
B. Wu, Cloer, C., Lu, P., Milazi, S., Shaban, M., Shah, S. N., Marston-Poe, L., Moulton, H. M., and Lu, Q. L., “Exon skipping restores dystrophin expression, but fails to prevent disease progression in later stage dystrophic dko mice.”, Gene Ther, vol. 21, no. 9, pp. 785-93, 2014.
N. Motamedi, Danelishvili, L., and Bermudez, L. E., “Identification of Mycobacterium avium genes associated with resistance to host antimicrobial peptides.”, J Med Microbiol, vol. 63, no. Pt 7, pp. 923-930, 2014.
L. Danelishvili, Stang, B., and Bermudez, L. E., “Identification of Mycobacterium avium genes expressed during in vivo infection and the role of the oligopeptide transporter OppA in virulence.”, Microb Pathog, vol. 76, pp. 67-76, 2014.
R. Rajsbaum, Versteeg, G. A., Schmid, S., Maestre, A. M., Belicha-Villanueva, A., Martínez-Romero, C., Patel, J. R., Morrison, J., Pisanelli, G., Miorin, L., Laurent-Rolle, M., Moulton, H. M., Stein, D. A., Fernandez-Sesma, A., tenOever, B. R., and García-Sastre, A., “Unanchored K48-linked polyubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKKε kinase-mediated antiviral response.”, Immunity, vol. 40, no. 6, pp. 880-95, 2014.

Pages